{"gene":"ABCD2","run_date":"2026-06-09T22:02:36","timeline":{"discoveries":[{"year":2004,"finding":"ABCD2 (ALDR) overexpression in Abcd1-knockout mice prevents both VLCFA accumulation and neurodegenerative features (axonal damage, myelin degeneration), demonstrating functional redundancy/overlap with ABCD1 in vivo. Double Abcd1/Abcd2 knockout mice show earlier onset and more severe disease including inflammatory signs, confirming overlapping in vivo function.","method":"Transgenic mouse overexpression of ABCD2 in Abcd1-/- background; double knockout mouse phenotypic analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic rescue and double-KO epistasis in vivo, replicated across multiple mouse lines with clear phenotypic readouts","pmids":["15489218"],"is_preprint":false},{"year":2010,"finding":"ABCD2 and ABCD1 have distinct substrate specificities for peroxisomal fatty acid β-oxidation: ABCD2 preferentially rescues β-oxidation of C22:0, C24:6, and especially C22:6 (DHA), while ABCD1 best rescues C24:0 and C26:0, as shown in a yeast complementation system. Both can function as homodimers.","method":"Yeast (Saccharomyces cerevisiae) pxa1/pxa2Δ complementation with human ABCD1 or ABCD2; radiolabeled fatty acid β-oxidation assays","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution/complementation system with defined substrates, single lab but multiple substrates tested with orthogonal readouts","pmids":["21145416"],"is_preprint":false},{"year":2008,"finding":"ABCD2 plays a specific role in degradation of long-chain saturated and omega9-monounsaturated fatty acids and in synthesis of docosahexaenoic acid (DHA); defective VLCFA β-oxidation was demonstrated ex vivo in brain slices of Abcd2-knockout mice using radiolabeled hexacosanoic acid and DHA precursor.","method":"Abcd2-knockout mouse; fatty acid profiling in organs and primary neurons; radiolabeled β-oxidation assays in brain slices","journal":"American journal of physiology. Endocrinology and metabolism","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean KO with defined metabolic phenotype and direct ex vivo enzymatic assay, single lab with multiple orthogonal methods","pmids":["18854420"],"is_preprint":false},{"year":2005,"finding":"Abcd2-knockout mice develop late-onset cerebellar and sensory ataxia with loss of Purkinje cells and dorsal root ganglion degeneration correlated with VLCFA accumulation. Mitochondrial, Golgi, and endoplasmic reticulum damage were identified as underlying pathological mechanisms, indicating disturbed organelle cross-talk.","method":"Abcd2-/- mouse generation and characterization; histopathology; electron microscopy of organelles","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean KO mouse with defined cellular phenotype, organelle damage characterized by electron microscopy, single lab with multiple orthogonal methods","pmids":["16223892"],"is_preprint":false},{"year":2011,"finding":"ABCD2 (ALDRP) physically interacts with ABCD1 (ALDP), demonstrated by proximity ligation assay and co-immunoprecipitation. A non-functional ALDRP-EGFP mutant exerts a transdominant-negative effect on ABCD1 function, mediated through this physical interaction. ABCD2 expression levels inversely correlate with saturated and monounsaturated VLCFA content and specifically supports DHA metabolism.","method":"Proximity ligation assay; co-immunoprecipitation; dose-dependent inducible expression of wild-type and ATPase-dead ALDRP-EGFP; fatty acid content analysis; β-oxidation assays for C26:0, C24:0, and C22:6","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP plus proximity ligation plus functional transdominant-negative assay, single lab but three orthogonal methods","pmids":["21209459"],"is_preprint":false},{"year":2001,"finding":"ABCD2 gene induction by fibrates is dependent on PPARα: fibrate treatment failed to induce ABCD2 in PPARα-/- knockout mice. However, a functional PPRE could not be identified in the ABCD2 promoter, suggesting an indirect PPARα-dependent mechanism.","method":"PPARα-/- knockout mice treated with fenofibrate; ABCD2 promoter cloning and analysis; gel-shift assay; COS-7 cell transfection reporter assay","journal":"European journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO plus promoter reporter assay, but mechanism remains indirect/incompletely defined","pmids":["11422379"],"is_preprint":false},{"year":2002,"finding":"ABCD2 expression is induced by sterol depletion via activation of SREBP transcription factors. A functional sterol regulatory element (SRE) was identified in the proximal ABCD2 promoter. ABCD2 induction by sterol depletion significantly reduced VLCFA accumulation in X-ALD fibroblasts.","method":"Real-time PCR in human fibroblasts and monocytes; reporter gene studies; site-directed mutagenesis of SRE; gel shift assays; VLCFA measurement in X-ALD fibroblasts","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 / Moderate — site-directed mutagenesis of promoter element, gel shift, and reporter assay with functional VLCFA readout, single lab with multiple orthogonal methods","pmids":["12374760"],"is_preprint":false},{"year":2005,"finding":"LXRα acts as a negative modulator of Abcd2 expression through a novel mechanism involving overlapping SREBP1c and LXRα binding sites (SRE/DR-4) in the Abcd2 promoter. In liver, concurrent LXRα and SREBP1c activation suppresses Abcd2, while hepatic Abcd2 expression in LXRα,β-deficient mice is induced to levels vastly exceeding wild type.","method":"LXRα/β knockout mice; fasting-refeeding and cholesterol-loading paradigms; promoter EMSA with nuclear extracts; cell culture reporter assays with SREBP1c and LXR ligands","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — genetic KO, EMSA with nuclear extracts, and reporter assays with defined mutations, single lab with multiple orthogonal methods","pmids":["16249184"],"is_preprint":false},{"year":2003,"finding":"ABCD2 is a direct transcriptional target of thyroid hormone (T3) signaling: its promoter contains a functional thyroid hormone response element that binds RXR/TRβ heterodimer. T3 treatment induces ABCD2 in rat liver in a TRβ-dependent manner (absent in TRβ-/- mice). In oligodendrocytes (differentiated CG4 cells) T3 induces ABCD2, and in X-ALD fibroblasts this induction correlates with normalization of VLCFA β-oxidation.","method":"TRβ-/- knockout mice treated with T3; gel-shift/EMSA for TRβ/RXR binding to promoter element; reporter assays in CG4 oligodendrocytes; VLCFA β-oxidation measurement in X-ALD fibroblasts","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — genetic KO, EMSA binding assay, reporter assay, and functional VLCFA readout in disease cells, single lab with multiple orthogonal approaches","pmids":["12761339"],"is_preprint":false},{"year":2008,"finding":"TRα and TRβ differentially modulate SREBP1-activated ABCD2 expression at overlapping SRE/DR-4 promoter elements. Unliganded TRβ represses ABCD2 independently of DNA binding, while T3-dependent activation requires TRα and intact SRE/DR-4 motifs. In vivo, temporal repression of Abcd2 in adult liver is blunted in TRβ-deficient mice, and T3-state responses are abrogated in TRα-deficient mice.","method":"TRα-/- and TRβ-/- mouse models; EMSA with nuclear extracts; reporter assays; RT-PCR","journal":"European journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — two genetic KO models, EMSA, and reporter assays; single lab with multiple orthogonal methods","pmids":["18834645"],"is_preprint":false},{"year":1999,"finding":"Human ABCD2 (ALDRP) protein localizes exclusively to peroxisomes. The ALDR gene spans 33 kb on chromosome 12q12 and consists of 10 exons with a gene structure highly similar to the ALD gene.","method":"Subcellular fractionation; immunofluorescence microscopy; cDNA cloning and genomic sequencing","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct subcellular fractionation and microscopy for localization, single lab, two orthogonal methods","pmids":["10329405"],"is_preprint":false},{"year":2006,"finding":"Overexpressed ABCD2 (ALDRP) in Sf21 insect cells exhibits ADP-binding activity but scarcely binds ATP, in contrast to ABCD1 (ALDP) which binds both ADP and ATP. ATPase activity was detectable in membranes expressing ABCD1 but membranous components appear required for activity.","method":"Baculovirus expression in Sf21 insect cells; immunoelectron microscopy; ATP/ADP-agarose binding; ATPase activity assay in membrane fractions","journal":"Biological & pharmaceutical bulletin","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro biochemical assay with recombinant protein, but single lab and limited controls for membrane topology","pmids":["16946495"],"is_preprint":false},{"year":2007,"finding":"Loss of Abcd2 (but not Abcd1) causes oxidative damage in the mouse adrenal gland, demonstrated by spontaneous and premature ceroid deposition (an end-product of oxidative damage) predominantly in adrenal medullary cells, and increased mitochondrial MnSOD immunoreactivity indicating oxidative stress.","method":"Abcd1-/- and Abcd2-/- knockout mice; immunohistochemistry for MnSOD and ceroid; histopathological analysis","journal":"Laboratory investigation; a journal of technical methods and pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO comparison with defined oxidative damage readout, single lab, two orthogonal methods","pmids":["17260006"],"is_preprint":false},{"year":2008,"finding":"siRNA-mediated silencing of Abcd1 and Abcd2 genes in primary mouse astrocytes causes VLCFA accumulation and induces an inflammatory response mediated by transcription factors NF-κB, AP-1, and C/EBP, establishing a direct mechanistic link between VLCFA accumulation and neuroinflammation.","method":"siRNA knockdown of Abcd1 and Abcd2 in primary mouse astrocytes; VLCFA measurement; inflammatory cytokine and iNOS expression; rescue with monoenoic fatty acids","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct RNAi KD with defined inflammatory phenotype and metabolic rescue, single lab with multiple readouts","pmids":["18723473"],"is_preprint":false},{"year":2014,"finding":"Abcd2 acts as a strong modifier of VLCFA metabolism in peritoneal macrophages: Abcd1/Abcd2 double-deficiency results in sixfold VLCFA (C26:0) accumulation and only 29% residual peroxisomal β-oxidation activity, compared to approximately twofold accumulation and 62% residual activity in Abcd1 single deficiency. Single Abcd2 deficiency alone did not compromise C26:0 β-oxidation, indicating Abcd2-mediated compensatory transport.","method":"Peritoneal macrophages from Abcd1-/-, Abcd2-/-, and Abcd1/Abcd2 double-knockout mice; gas chromatography–mass spectrometry for VLCFA; radiolabeled β-oxidation assays","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean genetic comparison across four genotypes with quantitative β-oxidation and GC-MS, single lab with two orthogonal methods","pmids":["25255441"],"is_preprint":false},{"year":2013,"finding":"ABCD2 is a direct transcriptional target of the β-catenin/TCF-4 pathway: two functional TCF-4 binding elements in the ABCD2 proximal promoter were identified by site-directed mutagenesis and chromatin immunoprecipitation. β-catenin/TCF-4 overexpression increases ABCD2 mRNA and reduces VLCFA levels.","method":"Promoter-reporter assays; site-directed mutagenesis of TCF-4 binding elements; chromatin immunoprecipitation; RT-PCR in HCC cells and X-ALD fibroblasts; VLCFA measurement","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — site-directed mutagenesis, ChIP, and functional VLCFA readout, single lab with multiple orthogonal methods","pmids":["23437103"],"is_preprint":false},{"year":2016,"finding":"Metformin-induced upregulation of ABCD2 in X-ALD fibroblasts and Abcd1-KO mouse brain/spinal cord is dependent on AMPKα1: ABCD2 induction by metformin was abolished in AMPKα1-KO primary mixed glial cells, placing ABCD2 downstream of the AMPK pathway.","method":"AMPKα1-KO mouse primary glial cells; X-ALD patient-derived fibroblasts; in vivo metformin treatment of Abcd1-KO mice; Western blot; VLCFA measurement","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO epistasis in primary cells plus in vivo validation, single lab with two orthogonal systems","pmids":["26849413"],"is_preprint":false},{"year":2010,"finding":"ABCD2 is highly expressed in adipose tissue (>50-fold over brain or adrenal) and opposes the accumulation of dietary erucic acid (C22:1): D2-/- mice challenged with erucic acid diet accumulate this lipid in adipose in a gene-dosage-dependent manner. ABCD2 is a SREBP target gene in adipocytes and is upregulated during adipogenesis.","method":"D2-/- knockout mice; dietary erucic acid challenge; fatty acid profiling; adipogenesis assays in mouse embryonic fibroblasts","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with gene-dosage dietary challenge, single lab with fatty acid profiling readout","pmids":["19556607"],"is_preprint":false},{"year":2014,"finding":"In adipose tissue, ABCD2 localizes to a distinct subclass of peroxisomes (~200 nm microperoxisomes) that are deficient in canonical peroxisome markers (catalase, PEX19, ABCD3) and whose proteome includes proteins associated with ER and mitochondria, suggesting physical association of this peroxisome subclass with these organelles.","method":"Subcellular fractionation; immunoisolation; electron microscopy; proteomics (mass spectrometry) of ABCD2-containing compartment; immunofluorescence with PEX19 antibody","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — immunoisolation with proteomics and electron microscopy, single lab with multiple orthogonal methods","pmids":["25446110"],"is_preprint":false},{"year":2000,"finding":"The ABCD2 promoter (1.3 kb of human or mouse 5'-upstream region) has functional promoter activity inducible by 9-cis-retinoic acid and forskolin in transfection assays; no PPARα-mediated induction was detected in this system.","method":"Promoter cloning; luciferase reporter transfection in cell lines; treatment with 9-cis-retinoic acid, forskolin, and PPARα ligands","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — reporter assay with defined stimuli, single lab, single method","pmids":["11087670"],"is_preprint":false},{"year":2007,"finding":"DHEA induces Abcd2 and Abcd3 (but not Abcd4) expression in rat hepatocytes and in vivo in rodent liver, but not in brain, testes, or adrenals. The induction mechanism for Abcd2 is independent of PPARα, in contrast to Abcd3.","method":"Primary rat hepatocyte cultures; in vivo DHEA treatment of rodents; RT-PCR; PPARα-knockout comparison","journal":"Biochimie","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo DHEA treatment with PPARα-KO genetic control, single lab","pmids":["17686565"],"is_preprint":false},{"year":2019,"finding":"CRISPR/Cas9-mediated combined knockout of Abcd1 and Abcd2 in BV-2 microglial cells results in VLCFA accumulation and formation of lipid inclusions similar to those in brain macrophages of X-ALD patients; single Abcd2 deficiency alone does not cause VLCFA accumulation, confirming functional redundancy.","method":"CRISPR/Cas9 double KO in BV-2 cells; electron microscopy; lipid analysis; cholesterol measurement","journal":"Biochimica et biophysica acta. Molecular and cell biology of lipids","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR KO with defined metabolic and ultrastructural phenotype, single lab with two orthogonal methods","pmids":["30769094"],"is_preprint":false}],"current_model":"ABCD2 (ALDRP) is a peroxisomal membrane ABC half-transporter that functions as a homodimer (and can heterodimerise with ABCD1) to transport CoA-esters of very long-chain and polyunsaturated fatty acids—particularly C22:0, C22:6 (DHA), and monounsaturated VLCFAs—into peroxisomes for β-oxidation; it displays substantial functional redundancy with ABCD1 in vivo, its loss causes VLCFA accumulation, oxidative organelle damage, and late-onset neurodegeneration in mice, and its expression is transcriptionally regulated by multiple pathways including SREBP/sterol depletion, LXRα (negatively), PPARα (indirectly via fibrates), thyroid hormone receptor TRβ/TRα, β-catenin/TCF-4, and AMPK, making it a validated therapeutic target for X-linked adrenoleukodystrophy."},"narrative":{"mechanistic_narrative":"ABCD2 (ALDRP) is a peroxisomal membrane ABC half-transporter that delivers very long-chain and polyunsaturated fatty acids into peroxisomes for β-oxidation and functions in close partnership with its paralog ABCD1 [PMID:15489218, PMID:10329405]. It localizes to peroxisomes and can act as a homodimer, and it also physically interacts with ABCD1 by co-immunoprecipitation and proximity ligation, such that an ATPase-dead ABCD2 mutant exerts a transdominant-negative effect on ABCD1 function [PMID:21209459, PMID:10329405]. The two transporters have overlapping but distinct substrate preferences: ABCD2 preferentially supports β-oxidation of C22:0, monounsaturated VLCFAs (including erucic acid C22:1), and especially C22:6/DHA, whereas ABCD1 best handles C24:0 and C26:0 [PMID:21145416, PMID:18854420, PMID:19556607]. This biochemistry underlies extensive in vivo redundancy — ABCD2 overexpression rescues VLCFA accumulation and neurodegeneration in Abcd1-null mice, single Abcd2 loss alone barely perturbs C26:0 β-oxidation, and only combined Abcd1/Abcd2 loss produces severe VLCFA accumulation, lipid inclusions, and disease, marking ABCD2 as a compensatory transporter and a therapeutic target for X-linked adrenoleukodystrophy [PMID:15489218, PMID:12374760, PMID:25255441, PMID:30769094]. Loss of ABCD2 causes VLCFA accumulation accompanied by mitochondrial, Golgi, and ER damage, adrenal oxidative damage, late-onset cerebellar and sensory ataxia in mice, and a VLCFA-driven NF-κB/AP-1/C/EBP inflammatory response in glia [PMID:16223892, PMID:17260006, PMID:18723473]. ABCD2 transcription is tightly and combinatorially regulated: it is induced by sterol depletion via an SRE bound by SREBP, negatively modulated by LXRα through overlapping SRE/DR-4 elements, activated by thyroid hormone through an RXR/TRβ-bound response element with differential TRα/TRβ control, induced indirectly via PPARα by fibrates, and driven by β-catenin/TCF-4 and by AMPKα1-dependent metformin signaling — and in several of these settings ABCD2 induction normalizes VLCFA β-oxidation in X-ALD cells [PMID:12374760, PMID:16249184, PMID:12761339, PMID:18834645, PMID:11422379, PMID:23437103, PMID:26849413].","teleology":[{"year":1999,"claim":"Establishing where ABCD2 acts: the protein was shown to reside exclusively in peroxisomes, fixing its functional compartment for fatty acid metabolism.","evidence":"Subcellular fractionation and immunofluorescence of human ALDRP, with gene structure mapping to 12q12","pmids":["10329405"],"confidence":"Medium","gaps":["Did not define substrate or transport activity","Membrane topology and dimerization state not addressed"]},{"year":2004,"claim":"Whether ABCD2 functionally overlaps with ABCD1 in vivo: ABCD2 overexpression rescued Abcd1-null pathology and double knockout aggravated disease, establishing genetic redundancy as the central feature of ABCD2 biology.","evidence":"Transgenic ABCD2 overexpression in Abcd1-/- mice and Abcd1/Abcd2 double-knockout phenotyping","pmids":["15489218"],"confidence":"High","gaps":["Did not resolve which specific substrates each transporter handles","Mechanism of compensation at the molecular level not defined"]},{"year":2005,"claim":"What ABCD2 loss does on its own: Abcd2-null mice developed late-onset ataxia, Purkinje cell and DRG loss with VLCFA accumulation, and damage to mitochondria, Golgi, and ER, revealing organelle cross-talk pathology.","evidence":"Abcd2-/- mouse histopathology and electron microscopy","pmids":["16223892"],"confidence":"High","gaps":["Causal link between VLCFA accumulation and organelle damage not mechanistically dissected","Why phenotype is late-onset unexplained"]},{"year":2008,"claim":"Defining ABCD2's metabolic specialty: ex vivo brain-slice β-oxidation assays showed ABCD2 supports degradation of saturated/omega9-monounsaturated VLCFAs and DHA synthesis, sharpening its substrate profile.","evidence":"Radiolabeled β-oxidation in Abcd2-KO brain slices plus organ and neuronal fatty acid profiling","pmids":["18854420"],"confidence":"High","gaps":["Direct transport (versus β-oxidation) not measured","DHA synthesis role mechanistically indirect"]},{"year":2010,"claim":"Distinguishing ABCD2 from ABCD1 biochemically: a yeast complementation system showed ABCD2 preferentially rescues C22:0, C24:6, and C22:6 (DHA) while ABCD1 favors C24:0/C26:0, and both work as homodimers.","evidence":"Yeast pxa1/pxa2Δ complementation with human ABCD1/ABCD2 and radiolabeled β-oxidation assays","pmids":["21145416"],"confidence":"High","gaps":["Substrate selectivity in a heterologous system may not fully reflect mammalian context","CoA-ester versus free fatty acid substrate not distinguished here"]},{"year":2011,"claim":"How ABCD2 and ABCD1 cooperate physically: reciprocal Co-IP and proximity ligation demonstrated direct interaction, and an ATPase-dead ABCD2 acted transdominant-negative on ABCD1, indicating heteromeric functional coupling.","evidence":"Proximity ligation, co-immunoprecipitation, and inducible WT/ATPase-dead ALDRP-EGFP with β-oxidation assays","pmids":["21209459"],"confidence":"High","gaps":["Stoichiometry of homodimer versus heterodimer in vivo unresolved","Structural basis of the interaction unknown"]},{"year":2014,"claim":"Quantifying the compensatory hierarchy: macrophage and CRISPR double-knockout studies showed single Abcd2 loss does not impair C26:0 β-oxidation while double loss collapses it, defining ABCD2 as a backup transporter unmasked only when ABCD1 is absent.","evidence":"Four-genotype peritoneal macrophage GC-MS/β-oxidation comparison and CRISPR double-KO in BV-2 microglia","pmids":["25255441","30769094"],"confidence":"High","gaps":["Tissue-specific thresholds of compensation not mapped","Why redundancy is incomplete for certain substrates unexplained"]},{"year":2008,"claim":"Linking transport loss to disease pathology: ABCD2 loss drives adrenal oxidative damage, and VLCFA accumulation from Abcd1/Abcd2 silencing triggers an NF-κB/AP-1/C/EBP inflammatory program in glia, connecting lipid transport defects to neuroinflammation.","evidence":"Abcd2-KO adrenal MnSOD/ceroid immunohistochemistry and siRNA knockdown in primary astrocytes with cytokine readouts and monoenoic-fatty-acid rescue","pmids":["17260006","18723473"],"confidence":"Medium","gaps":["Signaling steps from VLCFA to transcription factor activation not defined","siRNA off-target effects not fully controlled"]},{"year":2008,"claim":"Mapping transcriptional control: ABCD2 was shown to be combinatorially regulated by SREBP (sterol depletion, activating), LXRα (repressing via overlapping SRE/DR-4), thyroid hormone via RXR/TRβ with differential TRα/TRβ roles, and PPARα-dependent fibrate induction — several inducers normalizing VLCFA in X-ALD cells, establishing pharmacological levers.","evidence":"Promoter EMSA, site-directed mutagenesis, reporter assays, and KO mice (PPARα, LXRα/β, TRα, TRβ) with VLCFA β-oxidation readouts in X-ALD fibroblasts","pmids":["12374760","16249184","12761339","18834645","11422379"],"confidence":"High","gaps":["Indirect PPARα mechanism (no functional PPRE) unresolved","Integration of competing inputs at the SRE/DR-4 module in vivo not fully defined"]},{"year":2013,"claim":"Extending the regulatory network: β-catenin/TCF-4 and AMPKα1-dependent metformin signaling were identified as additional ABCD2 inducers, broadening the set of pathways exploitable to raise ABCD2 in X-ALD.","evidence":"ChIP and TCF-4-element mutagenesis with VLCFA readout; AMPKα1-KO glial epistasis plus in vivo metformin in Abcd1-KO mice","pmids":["23437103","26849413"],"confidence":"Medium","gaps":["Direct AMPK target element on ABCD2 promoter not identified","Cross-talk among these inducers untested"]},{"year":2014,"claim":"Tissue-specific biology: ABCD2 is highly enriched in adipose, opposes dietary erucic acid (C22:1) accumulation, and resides in a distinct ~200 nm microperoxisome subclass deficient in canonical peroxisomal markers yet enriched in ER/mitochondrial proteins, hinting at specialized organelle association.","evidence":"Dietary erucic acid challenge in D2-/- mice with fatty acid profiling; immunoisolation, proteomics, and EM of the ABCD2 compartment in adipose","pmids":["19556607","25446110"],"confidence":"Medium","gaps":["Functional significance of the microperoxisome subclass unknown","Whether ER/mitochondrial protein co-isolation reflects true contact sites unproven"]},{"year":2006,"claim":"Probing nucleotide handling: recombinant ABCD2 bound ADP but scarcely ATP, contrasting with ABCD1 which bound both, raising questions about its catalytic cycle that remain unresolved.","evidence":"Baculovirus expression in Sf21 cells with ATP/ADP-agarose binding and membrane ATPase assays","pmids":["16946495"],"confidence":"Medium","gaps":["Weak ATP binding may reflect non-native folding or missing membrane context","ATPase-coupled transport not directly reconstituted"]},{"year":null,"claim":"How ABCD2 couples ATP hydrolysis to fatty-acyl-CoA translocation across the peroxisomal membrane, and the structural basis for its substrate selectivity and ABCD1 heterodimerization, remain undefined.","evidence":"No reconstituted transport or structural study in the available corpus","pmids":[],"confidence":"Low","gaps":["No high-resolution structure","No purified-system transport assay defining the transported species","Stoichiometry and regulation of homo- versus heterodimers in vivo unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,2,14]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[11]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[1,2,17]}],"localization":[{"term_id":"GO:0005777","term_label":"peroxisome","supporting_discovery_ids":[10,18]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[1,2,14]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[6,7,8,15]}],"complexes":[],"partners":["ABCD1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UBJ2","full_name":"ATP-binding cassette sub-family D member 2","aliases":["Adrenoleukodystrophy-like 1","Adrenoleukodystrophy-related protein","hALDR"],"length_aa":740,"mass_kda":83.2,"function":"ATP-dependent transporter of the ATP-binding cassette (ABC) family involved in the transport of very long chain fatty acid (VLCFA)-CoA from the cytosol to the peroxisome lumen (PubMed:21145416, PubMed:29397936). Like ABCD1 seems to have fatty acyl-CoA thioesterase (ACOT) and ATPase activities, according to this model, VLCFA-CoA as free VLCFA is transpoted in an ATP-dependent manner into peroxisomes after the hydrolysis of VLCFA-CoA mediated by the ACOT activity of ABCD2 (Probable) (PubMed:29397936). Shows overlapping substrate specificities with ABCD1 toward saturated fatty acids (FA) and monounsaturated FA (MUFA) but has a distinct substrate preference for shorter VLCFA (C22:0) and polyunsaturated fatty acid (PUFA) such as C22:6-CoA and C24:6-CoA (in vitro) (PubMed:21145416). Thus, may play a role in regulation of VLCFAs and energy metabolism namely, in the degradation and biosynthesis of fatty acids by beta-oxidation (PubMed:21145416)","subcellular_location":"Peroxisome membrane","url":"https://www.uniprot.org/uniprotkb/Q9UBJ2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ABCD2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ABCD2","total_profiled":1310},"omim":[{"mim_id":"614362","title":"ACYL-CoA SYNTHETASE, BUBBLEGUM FAMILY, MEMBER 1; ACSBG1","url":"https://www.omim.org/entry/614362"},{"mim_id":"603214","title":"ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 4; ABCD4","url":"https://www.omim.org/entry/603214"},{"mim_id":"601081","title":"ATP-BINDING CASSETTE, SUBFAMILY 3, MEMBER 2; ABCD2","url":"https://www.omim.org/entry/601081"},{"mim_id":"300371","title":"ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 1; ABCD1","url":"https://www.omim.org/entry/300371"},{"mim_id":"300100","title":"ADRENOLEUKODYSTROPHY; ALD","url":"https://www.omim.org/entry/300100"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"adipose tissue","ntpm":14.8}],"url":"https://www.proteinatlas.org/search/ABCD2"},"hgnc":{"alias_symbol":["ALDR","ALDRP"],"prev_symbol":["ALDL1"]},"alphafold":{"accession":"Q9UBJ2","domains":[{"cath_id":"1.20.1560.10","chopping":"78-436","consensus_level":"medium","plddt":86.6187,"start":78,"end":436},{"cath_id":"3.40.50.300","chopping":"471-688","consensus_level":"high","plddt":91.4462,"start":471,"end":688},{"cath_id":"1.10.287","chopping":"697-739","consensus_level":"high","plddt":73.076,"start":697,"end":739}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UBJ2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UBJ2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UBJ2-F1-predicted_aligned_error_v6.png","plddt_mean":81.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ABCD2","jax_strain_url":"https://www.jax.org/strain/search?query=ABCD2"},"sequence":{"accession":"Q9UBJ2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UBJ2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UBJ2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UBJ2"}},"corpus_meta":[{"pmid":"15489218","id":"PMC_15489218","title":"Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy.","date":"2004","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15489218","citation_count":163,"is_preprint":false},{"pmid":"21145416","id":"PMC_21145416","title":"Differential substrate specificities of human ABCD1 and ABCD2 in peroxisomal fatty acid β-oxidation.","date":"2010","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/21145416","citation_count":109,"is_preprint":false},{"pmid":"18854420","id":"PMC_18854420","title":"A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis.","date":"2008","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/18854420","citation_count":88,"is_preprint":false},{"pmid":"16223892","id":"PMC_16223892","title":"Inactivation of the peroxisomal ABCD2 transporter in the mouse leads to late-onset ataxia involving mitochondria, Golgi and endoplasmic reticulum damage.","date":"2005","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16223892","citation_count":84,"is_preprint":false},{"pmid":"18723473","id":"PMC_18723473","title":"Silencing of Abcd1 and Abcd2 genes sensitizes astrocytes for inflammation: implication for X-adrenoleukodystrophy.","date":"2008","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/18723473","citation_count":55,"is_preprint":false},{"pmid":"11422379","id":"PMC_11422379","title":"Fibrate induction of the adrenoleukodystrophy-related gene (ABCD2): promoter analysis and role of the peroxisome proliferator-activated receptor PPARalpha.","date":"2001","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11422379","citation_count":53,"is_preprint":false},{"pmid":"12374760","id":"PMC_12374760","title":"Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy.","date":"2002","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12374760","citation_count":44,"is_preprint":false},{"pmid":"30769094","id":"PMC_30769094","title":"CRISPR/Cas9-mediated knockout of Abcd1 and Abcd2 genes in BV-2 cells: novel microglial models for X-linked Adrenoleukodystrophy.","date":"2019","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/30769094","citation_count":39,"is_preprint":false},{"pmid":"21209459","id":"PMC_21209459","title":"Substrate specificity overlap and interaction between adrenoleukodystrophy protein (ALDP/ABCD1) and adrenoleukodystrophy-related protein (ALDRP/ABCD2).","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21209459","citation_count":37,"is_preprint":false},{"pmid":"16249184","id":"PMC_16249184","title":"Liver X receptor alpha interferes with SREBP1c-mediated Abcd2 expression. Novel cross-talk in gene regulation.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16249184","citation_count":35,"is_preprint":false},{"pmid":"12761339","id":"PMC_12761339","title":"Thyroid hormone induction of the adrenoleukodystrophy-related gene (ABCD2).","date":"2003","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12761339","citation_count":34,"is_preprint":false},{"pmid":"17260006","id":"PMC_17260006","title":"The role of peroxisomal ABC transporters in the mouse adrenal gland: the loss of Abcd2 (ALDR), Not Abcd1 (ALD), causes oxidative damage.","date":"2007","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17260006","citation_count":33,"is_preprint":false},{"pmid":"19406244","id":"PMC_19406244","title":"Induction of the adrenoleukodystrophy-related gene (ABCD2) by thyromimetics.","date":"2009","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19406244","citation_count":29,"is_preprint":false},{"pmid":"20661612","id":"PMC_20661612","title":"Identification of novel SNPs of ABCD1, ABCD2, ABCD3, and ABCD4 genes in patients with X-linked adrenoleukodystrophy (ALD) based on comprehensive resequencing and association studies with ALD phenotypes.","date":"2010","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/20661612","citation_count":28,"is_preprint":false},{"pmid":"19556607","id":"PMC_19556607","title":"ABCD2 is abundant in adipose tissue and opposes the accumulation of dietary erucic acid (C22:1) in fat.","date":"2010","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/19556607","citation_count":27,"is_preprint":false},{"pmid":"18834645","id":"PMC_18834645","title":"Distinct modulatory roles for thyroid hormone receptors TRalpha and TRbeta in SREBP1-activated ABCD2 expression.","date":"2008","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18834645","citation_count":23,"is_preprint":false},{"pmid":"25255441","id":"PMC_25255441","title":"Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient mice.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25255441","citation_count":21,"is_preprint":false},{"pmid":"18834860","id":"PMC_18834860","title":"X-linked adrenoleukodystrophy phenotype is independent of ABCD2 genotype.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18834860","citation_count":21,"is_preprint":false},{"pmid":"21299488","id":"PMC_21299488","title":"Clinical predictive value of the ABCD2 score for early risk of stroke in patients who have had transient ischaemic attack and who present to an Australian tertiary hospital.","date":"2011","source":"The Medical journal of Australia","url":"https://pubmed.ncbi.nlm.nih.gov/21299488","citation_count":20,"is_preprint":false},{"pmid":"11087670","id":"PMC_11087670","title":"Characterization of the adrenoleukodystrophy-related (ALDR, ABCD2) gene promoter: inductibility by retinoic acid and forskolin.","date":"2000","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/11087670","citation_count":19,"is_preprint":false},{"pmid":"26849413","id":"PMC_26849413","title":"Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.","date":"2016","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26849413","citation_count":19,"is_preprint":false},{"pmid":"23318275","id":"PMC_23318275","title":"Caffeic acid phenethyl ester induces adrenoleukodystrophy (Abcd2) gene in human X-ALD fibroblasts and inhibits the proinflammatory response in Abcd1/2 silenced mouse primary astrocytes.","date":"2013","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/23318275","citation_count":19,"is_preprint":false},{"pmid":"19717021","id":"PMC_19717021","title":"D-dimer, magnetic resonance imaging diffusion-weighted imaging, and ABCD2 score for transient ischemic attack risk stratification.","date":"2009","source":"Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","url":"https://pubmed.ncbi.nlm.nih.gov/19717021","citation_count":19,"is_preprint":false},{"pmid":"10329405","id":"PMC_10329405","title":"Full length cDNA cloning, promoter sequence, and genomic organization of the human adrenoleukodystrophy related (ALDR) gene functionally redundant to the gene responsible for X-linked adrenoleukodystrophy.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10329405","citation_count":17,"is_preprint":false},{"pmid":"26195594","id":"PMC_26195594","title":"Regulation Mechanism of the ald Gene Encoding Alanine Dehydrogenase in Mycobacterium smegmatis and Mycobacterium tuberculosis by the Lrp/AsnC Family Regulator AldR.","date":"2015","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/26195594","citation_count":16,"is_preprint":false},{"pmid":"11342107","id":"PMC_11342107","title":"Rat adrenoleukodystrophy-related (ALDR) gene: full-length cDNA sequence and new insight in expression.","date":"2001","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/11342107","citation_count":16,"is_preprint":false},{"pmid":"24556878","id":"PMC_24556878","title":"ALDR enhanced endothelial injury in hyperuricemia screened using SILAC.","date":"2014","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24556878","citation_count":15,"is_preprint":false},{"pmid":"27006398","id":"PMC_27006398","title":"Crystal Structure of Mycobacterium tuberculosis H37Rv AldR (Rv2779c), a Regulator of the ald Gene: DNA BINDING AND IDENTIFICATION OF SMALL MOLECULE INHIBITORS.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27006398","citation_count":14,"is_preprint":false},{"pmid":"30264402","id":"PMC_30264402","title":"Suppression of ABCD2 dysregulates lipid metabolism via dysregulation of miR-141:ACSL4 in human osteoarthritis.","date":"2018","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/30264402","citation_count":14,"is_preprint":false},{"pmid":"24480443","id":"PMC_24480443","title":"Regulation of the adrenoleukodystrophy-related gene (ABCD2): focus on oxysterols and LXR antagonists.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/24480443","citation_count":13,"is_preprint":false},{"pmid":"24239766","id":"PMC_24239766","title":"LXR antagonists induce ABCD2 expression.","date":"2014","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/24239766","citation_count":13,"is_preprint":false},{"pmid":"23749971","id":"PMC_23749971","title":"Regulation of the ald gene encoding alanine dehydrogenase by AldR in Mycobacterium smegmatis.","date":"2013","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/23749971","citation_count":13,"is_preprint":false},{"pmid":"23437103","id":"PMC_23437103","title":"ABCD2 is a direct target of β-catenin and TCF-4: implications for X-linked adrenoleukodystrophy therapy.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23437103","citation_count":11,"is_preprint":false},{"pmid":"17686565","id":"PMC_17686565","title":"Dehydroepiandrosterone up-regulates the Adrenoleukodystrophy-related gene (ABCD2) independently of PPARalpha in rodents.","date":"2007","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/17686565","citation_count":9,"is_preprint":false},{"pmid":"26681085","id":"PMC_26681085","title":"Whole exome sequencing analysis of ABCC8 and ABCD2 genes associating with clinical course of breast carcinoma.","date":"2015","source":"Physiological research","url":"https://pubmed.ncbi.nlm.nih.gov/26681085","citation_count":9,"is_preprint":false},{"pmid":"16946495","id":"PMC_16946495","title":"ATP-binding and -hydrolysis activities of ALDP (ABCD1) and ALDRP (ABCD2), human peroxisomal ABC proteins, overexpressed in Sf21 cells.","date":"2006","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/16946495","citation_count":8,"is_preprint":false},{"pmid":"28409470","id":"PMC_28409470","title":"Flow Cytometric Analysis of the Expression Pattern of Peroxisomal Proteins, Abcd1, Abcd2, and Abcd3 in BV-2 Murine Microglial Cells.","date":"2017","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/28409470","citation_count":8,"is_preprint":false},{"pmid":"40674914","id":"PMC_40674914","title":"Jiangtang Tiaozhi formula ameliorates MASLD by regulating liver ABCD2/PEX2/ATGL axis-mediated fatty acid metabolic reprogramming.","date":"2025","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/40674914","citation_count":7,"is_preprint":false},{"pmid":"25123288","id":"PMC_25123288","title":"ABCD2 alters peroxisome proliferator-activated receptor α signaling in vitro, but does not impair responses to fenofibrate therapy in a mouse model of diet-induced obesity.","date":"2014","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25123288","citation_count":7,"is_preprint":false},{"pmid":"35261213","id":"PMC_35261213","title":"Synthetic role of miR-200b-3p, ABCD2 score, and carotid ultrasound in the prediction of cerebral infarction in patients with transient ischemic attack.","date":"2022","source":"Brain and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/35261213","citation_count":7,"is_preprint":false},{"pmid":"25079382","id":"PMC_25079382","title":"Evaluation of retinoids for induction of the redundant gene ABCD2 as an alternative treatment option in X-linked adrenoleukodystrophy.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25079382","citation_count":6,"is_preprint":false},{"pmid":"23194953","id":"PMC_23194953","title":"Varying uses of the ABCD2 scoring system in primary and secondary care: a qualitative study.","date":"2012","source":"BMJ open","url":"https://pubmed.ncbi.nlm.nih.gov/23194953","citation_count":6,"is_preprint":false},{"pmid":"25446110","id":"PMC_25446110","title":"ABCD2 identifies a subclass of peroxisomes in mouse adipose tissue.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25446110","citation_count":5,"is_preprint":false},{"pmid":"35937714","id":"PMC_35937714","title":"Value of Serum Adiponectin Combined with ABCD2 in Predicting Cerebral Infarction Among Patients with Acute Isolated Vertigo.","date":"2022","source":"Neuropsychiatric disease and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/35937714","citation_count":3,"is_preprint":false},{"pmid":"36844629","id":"PMC_36844629","title":"Taxol‑resistant breast cancer cell‑derived exosome‑delivered miR‑187‑5p regulates the growth of breast cancer cells via ABCD2 and Wnt/β‑catenin signaling.","date":"2023","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/36844629","citation_count":2,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":26294,"output_tokens":5774,"usd":0.082746,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14493,"output_tokens":4546,"usd":0.093058,"stage2_stop_reason":"end_turn"},"total_usd":0.175804,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"ABCD2 (ALDR) overexpression in Abcd1-knockout mice prevents both VLCFA accumulation and neurodegenerative features (axonal damage, myelin degeneration), demonstrating functional redundancy/overlap with ABCD1 in vivo. Double Abcd1/Abcd2 knockout mice show earlier onset and more severe disease including inflammatory signs, confirming overlapping in vivo function.\",\n      \"method\": \"Transgenic mouse overexpression of ABCD2 in Abcd1-/- background; double knockout mouse phenotypic analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic rescue and double-KO epistasis in vivo, replicated across multiple mouse lines with clear phenotypic readouts\",\n      \"pmids\": [\"15489218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"ABCD2 and ABCD1 have distinct substrate specificities for peroxisomal fatty acid β-oxidation: ABCD2 preferentially rescues β-oxidation of C22:0, C24:6, and especially C22:6 (DHA), while ABCD1 best rescues C24:0 and C26:0, as shown in a yeast complementation system. Both can function as homodimers.\",\n      \"method\": \"Yeast (Saccharomyces cerevisiae) pxa1/pxa2Δ complementation with human ABCD1 or ABCD2; radiolabeled fatty acid β-oxidation assays\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution/complementation system with defined substrates, single lab but multiple substrates tested with orthogonal readouts\",\n      \"pmids\": [\"21145416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ABCD2 plays a specific role in degradation of long-chain saturated and omega9-monounsaturated fatty acids and in synthesis of docosahexaenoic acid (DHA); defective VLCFA β-oxidation was demonstrated ex vivo in brain slices of Abcd2-knockout mice using radiolabeled hexacosanoic acid and DHA precursor.\",\n      \"method\": \"Abcd2-knockout mouse; fatty acid profiling in organs and primary neurons; radiolabeled β-oxidation assays in brain slices\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined metabolic phenotype and direct ex vivo enzymatic assay, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"18854420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Abcd2-knockout mice develop late-onset cerebellar and sensory ataxia with loss of Purkinje cells and dorsal root ganglion degeneration correlated with VLCFA accumulation. Mitochondrial, Golgi, and endoplasmic reticulum damage were identified as underlying pathological mechanisms, indicating disturbed organelle cross-talk.\",\n      \"method\": \"Abcd2-/- mouse generation and characterization; histopathology; electron microscopy of organelles\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO mouse with defined cellular phenotype, organelle damage characterized by electron microscopy, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"16223892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ABCD2 (ALDRP) physically interacts with ABCD1 (ALDP), demonstrated by proximity ligation assay and co-immunoprecipitation. A non-functional ALDRP-EGFP mutant exerts a transdominant-negative effect on ABCD1 function, mediated through this physical interaction. ABCD2 expression levels inversely correlate with saturated and monounsaturated VLCFA content and specifically supports DHA metabolism.\",\n      \"method\": \"Proximity ligation assay; co-immunoprecipitation; dose-dependent inducible expression of wild-type and ATPase-dead ALDRP-EGFP; fatty acid content analysis; β-oxidation assays for C26:0, C24:0, and C22:6\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP plus proximity ligation plus functional transdominant-negative assay, single lab but three orthogonal methods\",\n      \"pmids\": [\"21209459\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"ABCD2 gene induction by fibrates is dependent on PPARα: fibrate treatment failed to induce ABCD2 in PPARα-/- knockout mice. However, a functional PPRE could not be identified in the ABCD2 promoter, suggesting an indirect PPARα-dependent mechanism.\",\n      \"method\": \"PPARα-/- knockout mice treated with fenofibrate; ABCD2 promoter cloning and analysis; gel-shift assay; COS-7 cell transfection reporter assay\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO plus promoter reporter assay, but mechanism remains indirect/incompletely defined\",\n      \"pmids\": [\"11422379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ABCD2 expression is induced by sterol depletion via activation of SREBP transcription factors. A functional sterol regulatory element (SRE) was identified in the proximal ABCD2 promoter. ABCD2 induction by sterol depletion significantly reduced VLCFA accumulation in X-ALD fibroblasts.\",\n      \"method\": \"Real-time PCR in human fibroblasts and monocytes; reporter gene studies; site-directed mutagenesis of SRE; gel shift assays; VLCFA measurement in X-ALD fibroblasts\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — site-directed mutagenesis of promoter element, gel shift, and reporter assay with functional VLCFA readout, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"12374760\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"LXRα acts as a negative modulator of Abcd2 expression through a novel mechanism involving overlapping SREBP1c and LXRα binding sites (SRE/DR-4) in the Abcd2 promoter. In liver, concurrent LXRα and SREBP1c activation suppresses Abcd2, while hepatic Abcd2 expression in LXRα,β-deficient mice is induced to levels vastly exceeding wild type.\",\n      \"method\": \"LXRα/β knockout mice; fasting-refeeding and cholesterol-loading paradigms; promoter EMSA with nuclear extracts; cell culture reporter assays with SREBP1c and LXR ligands\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — genetic KO, EMSA with nuclear extracts, and reporter assays with defined mutations, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"16249184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ABCD2 is a direct transcriptional target of thyroid hormone (T3) signaling: its promoter contains a functional thyroid hormone response element that binds RXR/TRβ heterodimer. T3 treatment induces ABCD2 in rat liver in a TRβ-dependent manner (absent in TRβ-/- mice). In oligodendrocytes (differentiated CG4 cells) T3 induces ABCD2, and in X-ALD fibroblasts this induction correlates with normalization of VLCFA β-oxidation.\",\n      \"method\": \"TRβ-/- knockout mice treated with T3; gel-shift/EMSA for TRβ/RXR binding to promoter element; reporter assays in CG4 oligodendrocytes; VLCFA β-oxidation measurement in X-ALD fibroblasts\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — genetic KO, EMSA binding assay, reporter assay, and functional VLCFA readout in disease cells, single lab with multiple orthogonal approaches\",\n      \"pmids\": [\"12761339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TRα and TRβ differentially modulate SREBP1-activated ABCD2 expression at overlapping SRE/DR-4 promoter elements. Unliganded TRβ represses ABCD2 independently of DNA binding, while T3-dependent activation requires TRα and intact SRE/DR-4 motifs. In vivo, temporal repression of Abcd2 in adult liver is blunted in TRβ-deficient mice, and T3-state responses are abrogated in TRα-deficient mice.\",\n      \"method\": \"TRα-/- and TRβ-/- mouse models; EMSA with nuclear extracts; reporter assays; RT-PCR\",\n      \"journal\": \"European journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two genetic KO models, EMSA, and reporter assays; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"18834645\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Human ABCD2 (ALDRP) protein localizes exclusively to peroxisomes. The ALDR gene spans 33 kb on chromosome 12q12 and consists of 10 exons with a gene structure highly similar to the ALD gene.\",\n      \"method\": \"Subcellular fractionation; immunofluorescence microscopy; cDNA cloning and genomic sequencing\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct subcellular fractionation and microscopy for localization, single lab, two orthogonal methods\",\n      \"pmids\": [\"10329405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Overexpressed ABCD2 (ALDRP) in Sf21 insect cells exhibits ADP-binding activity but scarcely binds ATP, in contrast to ABCD1 (ALDP) which binds both ADP and ATP. ATPase activity was detectable in membranes expressing ABCD1 but membranous components appear required for activity.\",\n      \"method\": \"Baculovirus expression in Sf21 insect cells; immunoelectron microscopy; ATP/ADP-agarose binding; ATPase activity assay in membrane fractions\",\n      \"journal\": \"Biological & pharmaceutical bulletin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro biochemical assay with recombinant protein, but single lab and limited controls for membrane topology\",\n      \"pmids\": [\"16946495\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Loss of Abcd2 (but not Abcd1) causes oxidative damage in the mouse adrenal gland, demonstrated by spontaneous and premature ceroid deposition (an end-product of oxidative damage) predominantly in adrenal medullary cells, and increased mitochondrial MnSOD immunoreactivity indicating oxidative stress.\",\n      \"method\": \"Abcd1-/- and Abcd2-/- knockout mice; immunohistochemistry for MnSOD and ceroid; histopathological analysis\",\n      \"journal\": \"Laboratory investigation; a journal of technical methods and pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO comparison with defined oxidative damage readout, single lab, two orthogonal methods\",\n      \"pmids\": [\"17260006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"siRNA-mediated silencing of Abcd1 and Abcd2 genes in primary mouse astrocytes causes VLCFA accumulation and induces an inflammatory response mediated by transcription factors NF-κB, AP-1, and C/EBP, establishing a direct mechanistic link between VLCFA accumulation and neuroinflammation.\",\n      \"method\": \"siRNA knockdown of Abcd1 and Abcd2 in primary mouse astrocytes; VLCFA measurement; inflammatory cytokine and iNOS expression; rescue with monoenoic fatty acids\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct RNAi KD with defined inflammatory phenotype and metabolic rescue, single lab with multiple readouts\",\n      \"pmids\": [\"18723473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Abcd2 acts as a strong modifier of VLCFA metabolism in peritoneal macrophages: Abcd1/Abcd2 double-deficiency results in sixfold VLCFA (C26:0) accumulation and only 29% residual peroxisomal β-oxidation activity, compared to approximately twofold accumulation and 62% residual activity in Abcd1 single deficiency. Single Abcd2 deficiency alone did not compromise C26:0 β-oxidation, indicating Abcd2-mediated compensatory transport.\",\n      \"method\": \"Peritoneal macrophages from Abcd1-/-, Abcd2-/-, and Abcd1/Abcd2 double-knockout mice; gas chromatography–mass spectrometry for VLCFA; radiolabeled β-oxidation assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic comparison across four genotypes with quantitative β-oxidation and GC-MS, single lab with two orthogonal methods\",\n      \"pmids\": [\"25255441\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ABCD2 is a direct transcriptional target of the β-catenin/TCF-4 pathway: two functional TCF-4 binding elements in the ABCD2 proximal promoter were identified by site-directed mutagenesis and chromatin immunoprecipitation. β-catenin/TCF-4 overexpression increases ABCD2 mRNA and reduces VLCFA levels.\",\n      \"method\": \"Promoter-reporter assays; site-directed mutagenesis of TCF-4 binding elements; chromatin immunoprecipitation; RT-PCR in HCC cells and X-ALD fibroblasts; VLCFA measurement\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — site-directed mutagenesis, ChIP, and functional VLCFA readout, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"23437103\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Metformin-induced upregulation of ABCD2 in X-ALD fibroblasts and Abcd1-KO mouse brain/spinal cord is dependent on AMPKα1: ABCD2 induction by metformin was abolished in AMPKα1-KO primary mixed glial cells, placing ABCD2 downstream of the AMPK pathway.\",\n      \"method\": \"AMPKα1-KO mouse primary glial cells; X-ALD patient-derived fibroblasts; in vivo metformin treatment of Abcd1-KO mice; Western blot; VLCFA measurement\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO epistasis in primary cells plus in vivo validation, single lab with two orthogonal systems\",\n      \"pmids\": [\"26849413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"ABCD2 is highly expressed in adipose tissue (>50-fold over brain or adrenal) and opposes the accumulation of dietary erucic acid (C22:1): D2-/- mice challenged with erucic acid diet accumulate this lipid in adipose in a gene-dosage-dependent manner. ABCD2 is a SREBP target gene in adipocytes and is upregulated during adipogenesis.\",\n      \"method\": \"D2-/- knockout mice; dietary erucic acid challenge; fatty acid profiling; adipogenesis assays in mouse embryonic fibroblasts\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with gene-dosage dietary challenge, single lab with fatty acid profiling readout\",\n      \"pmids\": [\"19556607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In adipose tissue, ABCD2 localizes to a distinct subclass of peroxisomes (~200 nm microperoxisomes) that are deficient in canonical peroxisome markers (catalase, PEX19, ABCD3) and whose proteome includes proteins associated with ER and mitochondria, suggesting physical association of this peroxisome subclass with these organelles.\",\n      \"method\": \"Subcellular fractionation; immunoisolation; electron microscopy; proteomics (mass spectrometry) of ABCD2-containing compartment; immunofluorescence with PEX19 antibody\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — immunoisolation with proteomics and electron microscopy, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"25446110\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The ABCD2 promoter (1.3 kb of human or mouse 5'-upstream region) has functional promoter activity inducible by 9-cis-retinoic acid and forskolin in transfection assays; no PPARα-mediated induction was detected in this system.\",\n      \"method\": \"Promoter cloning; luciferase reporter transfection in cell lines; treatment with 9-cis-retinoic acid, forskolin, and PPARα ligands\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — reporter assay with defined stimuli, single lab, single method\",\n      \"pmids\": [\"11087670\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"DHEA induces Abcd2 and Abcd3 (but not Abcd4) expression in rat hepatocytes and in vivo in rodent liver, but not in brain, testes, or adrenals. The induction mechanism for Abcd2 is independent of PPARα, in contrast to Abcd3.\",\n      \"method\": \"Primary rat hepatocyte cultures; in vivo DHEA treatment of rodents; RT-PCR; PPARα-knockout comparison\",\n      \"journal\": \"Biochimie\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo DHEA treatment with PPARα-KO genetic control, single lab\",\n      \"pmids\": [\"17686565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CRISPR/Cas9-mediated combined knockout of Abcd1 and Abcd2 in BV-2 microglial cells results in VLCFA accumulation and formation of lipid inclusions similar to those in brain macrophages of X-ALD patients; single Abcd2 deficiency alone does not cause VLCFA accumulation, confirming functional redundancy.\",\n      \"method\": \"CRISPR/Cas9 double KO in BV-2 cells; electron microscopy; lipid analysis; cholesterol measurement\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular and cell biology of lipids\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR KO with defined metabolic and ultrastructural phenotype, single lab with two orthogonal methods\",\n      \"pmids\": [\"30769094\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ABCD2 (ALDRP) is a peroxisomal membrane ABC half-transporter that functions as a homodimer (and can heterodimerise with ABCD1) to transport CoA-esters of very long-chain and polyunsaturated fatty acids—particularly C22:0, C22:6 (DHA), and monounsaturated VLCFAs—into peroxisomes for β-oxidation; it displays substantial functional redundancy with ABCD1 in vivo, its loss causes VLCFA accumulation, oxidative organelle damage, and late-onset neurodegeneration in mice, and its expression is transcriptionally regulated by multiple pathways including SREBP/sterol depletion, LXRα (negatively), PPARα (indirectly via fibrates), thyroid hormone receptor TRβ/TRα, β-catenin/TCF-4, and AMPK, making it a validated therapeutic target for X-linked adrenoleukodystrophy.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ABCD2 (ALDRP) is a peroxisomal membrane ABC half-transporter that delivers very long-chain and polyunsaturated fatty acids into peroxisomes for β-oxidation and functions in close partnership with its paralog ABCD1 [#0, #10]. It localizes to peroxisomes and can act as a homodimer, and it also physically interacts with ABCD1 by co-immunoprecipitation and proximity ligation, such that an ATPase-dead ABCD2 mutant exerts a transdominant-negative effect on ABCD1 function [#4, #10]. The two transporters have overlapping but distinct substrate preferences: ABCD2 preferentially supports β-oxidation of C22:0, monounsaturated VLCFAs (including erucic acid C22:1), and especially C22:6/DHA, whereas ABCD1 best handles C24:0 and C26:0 [#1, #2, #17]. This biochemistry underlies extensive in vivo redundancy — ABCD2 overexpression rescues VLCFA accumulation and neurodegeneration in Abcd1-null mice, single Abcd2 loss alone barely perturbs C26:0 β-oxidation, and only combined Abcd1/Abcd2 loss produces severe VLCFA accumulation, lipid inclusions, and disease, marking ABCD2 as a compensatory transporter and a therapeutic target for X-linked adrenoleukodystrophy [#0, #6, #14, #21]. Loss of ABCD2 causes VLCFA accumulation accompanied by mitochondrial, Golgi, and ER damage, adrenal oxidative damage, late-onset cerebellar and sensory ataxia in mice, and a VLCFA-driven NF-κB/AP-1/C/EBP inflammatory response in glia [#3, #12, #13]. ABCD2 transcription is tightly and combinatorially regulated: it is induced by sterol depletion via an SRE bound by SREBP, negatively modulated by LXRα through overlapping SRE/DR-4 elements, activated by thyroid hormone through an RXR/TRβ-bound response element with differential TRα/TRβ control, induced indirectly via PPARα by fibrates, and driven by β-catenin/TCF-4 and by AMPKα1-dependent metformin signaling — and in several of these settings ABCD2 induction normalizes VLCFA β-oxidation in X-ALD cells [#6, #7, #8, #9, #5, #15, #16].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing where ABCD2 acts: the protein was shown to reside exclusively in peroxisomes, fixing its functional compartment for fatty acid metabolism.\",\n      \"evidence\": \"Subcellular fractionation and immunofluorescence of human ALDRP, with gene structure mapping to 12q12\",\n      \"pmids\": [\"10329405\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not define substrate or transport activity\", \"Membrane topology and dimerization state not addressed\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Whether ABCD2 functionally overlaps with ABCD1 in vivo: ABCD2 overexpression rescued Abcd1-null pathology and double knockout aggravated disease, establishing genetic redundancy as the central feature of ABCD2 biology.\",\n      \"evidence\": \"Transgenic ABCD2 overexpression in Abcd1-/- mice and Abcd1/Abcd2 double-knockout phenotyping\",\n      \"pmids\": [\"15489218\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve which specific substrates each transporter handles\", \"Mechanism of compensation at the molecular level not defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"What ABCD2 loss does on its own: Abcd2-null mice developed late-onset ataxia, Purkinje cell and DRG loss with VLCFA accumulation, and damage to mitochondria, Golgi, and ER, revealing organelle cross-talk pathology.\",\n      \"evidence\": \"Abcd2-/- mouse histopathology and electron microscopy\",\n      \"pmids\": [\"16223892\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Causal link between VLCFA accumulation and organelle damage not mechanistically dissected\", \"Why phenotype is late-onset unexplained\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defining ABCD2's metabolic specialty: ex vivo brain-slice β-oxidation assays showed ABCD2 supports degradation of saturated/omega9-monounsaturated VLCFAs and DHA synthesis, sharpening its substrate profile.\",\n      \"evidence\": \"Radiolabeled β-oxidation in Abcd2-KO brain slices plus organ and neuronal fatty acid profiling\",\n      \"pmids\": [\"18854420\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transport (versus β-oxidation) not measured\", \"DHA synthesis role mechanistically indirect\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Distinguishing ABCD2 from ABCD1 biochemically: a yeast complementation system showed ABCD2 preferentially rescues C22:0, C24:6, and C22:6 (DHA) while ABCD1 favors C24:0/C26:0, and both work as homodimers.\",\n      \"evidence\": \"Yeast pxa1/pxa2Δ complementation with human ABCD1/ABCD2 and radiolabeled β-oxidation assays\",\n      \"pmids\": [\"21145416\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Substrate selectivity in a heterologous system may not fully reflect mammalian context\", \"CoA-ester versus free fatty acid substrate not distinguished here\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"How ABCD2 and ABCD1 cooperate physically: reciprocal Co-IP and proximity ligation demonstrated direct interaction, and an ATPase-dead ABCD2 acted transdominant-negative on ABCD1, indicating heteromeric functional coupling.\",\n      \"evidence\": \"Proximity ligation, co-immunoprecipitation, and inducible WT/ATPase-dead ALDRP-EGFP with β-oxidation assays\",\n      \"pmids\": [\"21209459\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of homodimer versus heterodimer in vivo unresolved\", \"Structural basis of the interaction unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Quantifying the compensatory hierarchy: macrophage and CRISPR double-knockout studies showed single Abcd2 loss does not impair C26:0 β-oxidation while double loss collapses it, defining ABCD2 as a backup transporter unmasked only when ABCD1 is absent.\",\n      \"evidence\": \"Four-genotype peritoneal macrophage GC-MS/β-oxidation comparison and CRISPR double-KO in BV-2 microglia\",\n      \"pmids\": [\"25255441\", \"30769094\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific thresholds of compensation not mapped\", \"Why redundancy is incomplete for certain substrates unexplained\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Linking transport loss to disease pathology: ABCD2 loss drives adrenal oxidative damage, and VLCFA accumulation from Abcd1/Abcd2 silencing triggers an NF-κB/AP-1/C/EBP inflammatory program in glia, connecting lipid transport defects to neuroinflammation.\",\n      \"evidence\": \"Abcd2-KO adrenal MnSOD/ceroid immunohistochemistry and siRNA knockdown in primary astrocytes with cytokine readouts and monoenoic-fatty-acid rescue\",\n      \"pmids\": [\"17260006\", \"18723473\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Signaling steps from VLCFA to transcription factor activation not defined\", \"siRNA off-target effects not fully controlled\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Mapping transcriptional control: ABCD2 was shown to be combinatorially regulated by SREBP (sterol depletion, activating), LXRα (repressing via overlapping SRE/DR-4), thyroid hormone via RXR/TRβ with differential TRα/TRβ roles, and PPARα-dependent fibrate induction — several inducers normalizing VLCFA in X-ALD cells, establishing pharmacological levers.\",\n      \"evidence\": \"Promoter EMSA, site-directed mutagenesis, reporter assays, and KO mice (PPARα, LXRα/β, TRα, TRβ) with VLCFA β-oxidation readouts in X-ALD fibroblasts\",\n      \"pmids\": [\"12374760\", \"16249184\", \"12761339\", \"18834645\", \"11422379\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Indirect PPARα mechanism (no functional PPRE) unresolved\", \"Integration of competing inputs at the SRE/DR-4 module in vivo not fully defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Extending the regulatory network: β-catenin/TCF-4 and AMPKα1-dependent metformin signaling were identified as additional ABCD2 inducers, broadening the set of pathways exploitable to raise ABCD2 in X-ALD.\",\n      \"evidence\": \"ChIP and TCF-4-element mutagenesis with VLCFA readout; AMPKα1-KO glial epistasis plus in vivo metformin in Abcd1-KO mice\",\n      \"pmids\": [\"23437103\", \"26849413\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct AMPK target element on ABCD2 promoter not identified\", \"Cross-talk among these inducers untested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Tissue-specific biology: ABCD2 is highly enriched in adipose, opposes dietary erucic acid (C22:1) accumulation, and resides in a distinct ~200 nm microperoxisome subclass deficient in canonical peroxisomal markers yet enriched in ER/mitochondrial proteins, hinting at specialized organelle association.\",\n      \"evidence\": \"Dietary erucic acid challenge in D2-/- mice with fatty acid profiling; immunoisolation, proteomics, and EM of the ABCD2 compartment in adipose\",\n      \"pmids\": [\"19556607\", \"25446110\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional significance of the microperoxisome subclass unknown\", \"Whether ER/mitochondrial protein co-isolation reflects true contact sites unproven\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Probing nucleotide handling: recombinant ABCD2 bound ADP but scarcely ATP, contrasting with ABCD1 which bound both, raising questions about its catalytic cycle that remain unresolved.\",\n      \"evidence\": \"Baculovirus expression in Sf21 cells with ATP/ADP-agarose binding and membrane ATPase assays\",\n      \"pmids\": [\"16946495\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Weak ATP binding may reflect non-native folding or missing membrane context\", \"ATPase-coupled transport not directly reconstituted\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ABCD2 couples ATP hydrolysis to fatty-acyl-CoA translocation across the peroxisomal membrane, and the structural basis for its substrate selectivity and ABCD1 heterodimerization, remain undefined.\",\n      \"evidence\": \"No reconstituted transport or structural study in the available corpus\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure\", \"No purified-system transport assay defining the transported species\", \"Stoichiometry and regulation of homo- versus heterodimers in vivo unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 2, 14]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [11]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [1, 2, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005777\", \"supporting_discovery_ids\": [10, 18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [1, 2, 14]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [6, 7, 8, 15]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"ABCD1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}